Effects of inhaled furosemide on platelet-activating factor challenge in mild asthma

European Respiratory Journal

Volumn 14, Issue 3, 1999, Pages 616-621

  Echazarreta, A L ^a   Gomez F P ^a   Ribas, J ^a   Achaval, M ^a   Barbera J A ^a   Roca, J ^a   Chung, K F ^b   Rodriguez Roisin, R ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Airway obstruction; Bronchoconstriction; Diuretics; Inflammatory mediators; Leukotrienes; Pulmonary gas exchange

Indexed keywords

FUROSEMIDE; PEPTIDOLEUKOTRIENE; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTERIAL GAS; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG RESISTANCE; MALE; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADULT; AIRWAY RESISTANCE; ASTHMA; BLOOD GAS ANALYSIS; BRONCHOCONSTRICTION; CREATININE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; FUROSEMIDE; HUMANS; LEUKOCYTE COUNT; LEUKOTRIENE E4; MALE; NEBULIZERS AND VAPORIZERS; PLATELET ACTIVATING FACTOR; PULMONARY GAS EXCHANGE;

EID: 0345034791     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14c22.x     Document Type: Article

References (23)

1. Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997; 10: 1359-1371.
2. Chung KF, Barnes PJ. Loop diuretics and asthma. Pulm Pharmacol 1992; 5: 1-7.
3. Corboz MR, Ballard ST, Inglis ST, Taylor AE. Dilatory effect of furosemide on rat tracheal arterioles and venules. Am J Respir Crit Care Med 1997; 156: 478-483.
4. Anderson SD, Wei He BS. Inhibition by furosemide of inflammatory mediators from lung fragments (Letter to Editor). N Engl J Med 1990; 324: 131.
5. 4 in allergen-induced early asthmatic reactions (Abstract). Pharmacol Research 1992; 26: 36.
6. Gómez FP, Iglesia R, Roca J, Barbera JA, Chung KF, Rodriguez-Roisin R. The effect of 5-lipoxygenase inhibition by zileuton on platelet-activating factor-induced pulmonary abnormalities in mild asthma. Am J Respir Crit Care Med 1998; 157: 1559-1564.
7. Kumlin M. Measurements of leukotrienes in the urine: strategies and applications. Allergy 1997; 52: 124-135.
8. Rodriguez-Roisin R, Félez MA, Chung KF, et al Platelet-activating factor causes ventilation-perfusion mismatch in humans. J Clin Invest 1994; 93: 188-194.
9. Félez MA, Roca J, Barbera JA, et al. Inhaled platelet-activating factor worsens gas exchange in mild asthma. Am J Respir Crit Care Med 1994; 150: 369-373.
10. Díaz O, Barbera JA, Marrades R, Chung KF, Roca J, Rodriguez-Roisin R. Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation. Am J Respir Crit Care Med 1997; 156: 17-22.
11. Bianco S, Pieroni MG, Refini RM, Sestini P, Robuschi M, Vaghi A. Protective effect of inhaled loop diuretics on experimentally induced bronchoconstriction. In: Spector SL, editors. Provocation testing in clinical practice. New York, Marcel Dekker Inc., 1995; 411-423.
12. Lockhart A, Slutsky AS. Furosemide and loop diuretics in human asthma. Chest 1994; 106: 244-249.
13. O'Connor BJ, Chung KF, Chen-Worsdell YM, Fuller RW, Barnes PJ. Effect of inhaled furosemide and bumetanide on adenosine 5′-monophosphate-and sodium metabisulphite-induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis 1991; 143: 1329-1333.
14. Matsumoto K, Hashimoto S, Gon Y, Nakayam T, Hone T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J Allergy Clin Immunol 1998; 101: 825-831.
15. Marrades RM, Roca J, Barberà JA, de Jover LI, MacNee W, Rodriguez-Roisin R. Nebulized glutathione induces bronchoprovocation in patients with mild asthma. Am J Respir Crit Care Med 1997; 156: 425-430.
16. McFadden ER, Lenner KAM, Strohl KP. Postexertional airway rewarming and thermally induced asthma. J Clin Invest 1986; 78: 18-25.
17. Gilbert IA, Lenner A, Nelson JOA, Wolin AD, Fouke JM. Inhaled furosemide attenuates hyperpnea-induced obstruction and intra-airway thermal gradients. J Appl Physiol 1994; 76: 409-415.
18. Roca J, Félez MA, Chung KF, et al. Salbutamol inhibits pulmonary effects of platelet-activating factor in man. Am J Respir Crit Care Med 1995; 151: 1740-1744.
19. Masclans JR, Barberà JA, MacNee W, et al. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am J Respir Crit Care Med 1996; 154: 529-532.
20. Persson CGA. Tracheobronchial microcirculation in asthma. In: Kaliner JA, Barnes PJ, Persson C, eds. Asthma. Its pathology and treatment. New York, Marcel Dekker Inc., 1991; 209-229.
21. 4 release in stimulated alveolar macrophages from asthmatic patients. Eur Respir J 1998; 11: 1098-1104.
22. 2 production in humans. J Appl Physiol 1991; 71: 1396-1402.
23. Hui KP, Taylor IK, Taylor GW, et al. Effect of a 5-lip-oxygenase inhibitor on leukotriene generation and airway responses after allergen in asthmatic patients. Thorax 1991; 46: 184-189.